Romana Rysava Martina Peiskerova Vladimir Tesar Jan Benes Martin Kment Ágnes Szilágyi Dorottya Csuka Zoltán Prohászka
10.3389/fimmu.2022.1001366
Front Immunol
2022 Sep 28;13:1001366.
acute kidney injury atypical hemolytic uremic syndrome complement eculizumab genetic risk mrna vaccine against sars-cov-2 ravulizumab thrombotic microangiopathies
CC BY
https://pubmed.ncbi.nlm.nih.gov/36275662/
Acute Kidney Injury / complications Atypical Hemolytic Uremic Syndrome / diagnosis Atypical Hemolytic Uremic Syndrome / genetics COVID-19
Acute Kidney Injury / complications Atypical Hemolytic Uremic Syndrome / diagnosis Atypical Hemolytic Uremic Syndrome / genetics COVID-19 Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal COVID-19 Vaccines / adverse effects Complement Factor H / genetics Complement System Proteins / genetics Female Humans RNA, Messenger SARS-CoV-2 Vaccination / adverse effects mRNA Vaccine Complement Factor H RNA, Messenger COVID-19 Vaccines Complement System Proteins Antibodies, Monoclonal
PMC9580272
36275662
Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
2022